Patient-centered decision making: A view of the past and a look toward the future

Medical Decision Making

Volumn 21, Issue 3, 2001, Pages 241-247

  Eckman, Mark H ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE POLICY; HEALTH STATUS; MEDICAL DECISION MAKING; PATIENT CARE; PHYSICIAN ATTITUDE; REVIEW; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; DECISION MAKING; DECISION MAKING, COMPUTER-ASSISTED; DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; HUMANS; INTERNET; MALE; MODELS, THEORETICAL; PATIENT CARE PLANNING; PATIENT PARTICIPATION; RISK ASSESSMENT;

EID: 0035017061     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/02729890122062532     Document Type: Review

References (26)

1. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis [see comments]. Ann Intern Med. 1990;113(2):147-54.
2. Tengs TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness [see comments]. Risk Anal. 1995;15(3):369-90.
3. Ransohoff DF, Gracie WA, Wolfenson LB, Neuhauser D. Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. Ann Intern Med. 1983;99(2):199-204.
4. Molitch ME, Beck JR, Dreisman M, Gottlieb JE, Pauker SG. The cold thyroid nodule: an analysis of diagnostic and therapeutic options. Endocr Rev. 1984;5(2):185-99.
5. Pauker SG. Coronary artery surgery: the use of decision analysis. Ann Intern Med. 1976;85(1):8-18.
6. Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery. Circulation. 1982;66(5 Pt 2):III56-66.
7. Pauker SP, Pauker SG. The amniocentesis decision: ten years of decision analytic experience. Birth Defects Orig Arctic Ser. 1987;23(2):151-69.
8. Pauker SG, Pauker SP. Prescriptive models to support decision making in genetics. Birth Defects Orig Arctic Ser. 1987;23(2):279-96.
9. Tengs TO, Winer EP, Paddock S, Aguilar-Chavez O, Berry DA. Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis. Med Decis Making. 1998;18(4):365-75.
10. Tengs T, Berry D. The cost-effectiveness of testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes. Med Decis Making. 1999;19:526.
11. Stalmeier PF, Unic IJ, Verhoef LC, Van Daal WA. Evaluation of a shared decision making program for women suspected to have a genetic predisposition to breast cancer: preliminary results. Med Decis Making. 1999;19(3):230-41.
12. Stalmeier P, Unic I, Verhoef L, van Daal W. Prophylactic mastectomy or screening: a study of women's choices, medical and decision analytic recommendations. Med Decis Making. 1999;19:526.
13. Dembitzer A, Sanders G, Goldstein M, Owens D. Cost-effectiveness of programs that screen for BRCA mutations in women. Med Decis Making. 1999;19:526.
14. Barry MJ, Fowler FJ, Jr., Mulley AG, Jr., Henderson JV, Jr., Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care. 1995;33(8):771-82.
15. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154(13):1449-57. (A published erratum appears in Arch Intern Med. 1994;154(19):2254.)
16. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest. 1998;114(5 Suppl):579S-89S.
17. Thomson R, Parkin D, Eccles M, Sudlow M, Robinson A. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet. 2000;355:956-62.
18. Albers GW. Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med. 1994;154(13):1443-8.
19. Eckman MH, Pauker SG. Decision analytic issues in the management of atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanisms and Management. Philadelphia: Lippincott-Raven, 1997; p 469-88.
20. Eckman MH, Levine HJ, Salem DN, Pauker SG. Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues. Chest. 1998;114(5 Suppl):699S-714S.
21. Sanders GD, Hagerty CG, Sonnenberg FA, Hlatky MA, Owens DK. Distributed decision support using a Web-based interface: prevention of sudden cardiac death. Med Decis Making. 1999;19(2):157-66.
22. Molenaar S, Sprangers MA, Postma-Schuit FC, et al. Feasibility and effects of decision aids. Med Decis Making. 2000;20(1):112-27.
23. O'Connor AM, Rostom A, Fiset V, et al. Decision aids for patients facing health treatment or screening decisions: systematic review [see comments]. BMJ. 1999;319(7212):731-4.
24. Bekker H, Thornton J, Airey C, et al. Informed decision making: an annotated bibliography and systematic review. Health Technol Assess. 1999;3(1):1-156.
25. Kassirer JP, Pauker SG. The toss-up [editorial]. N Engl J Med. 1981;305(24):1467-9.
26. Tufte E. The Visual Display of Quantitative Information. Cheshire, CT: Graphics Press, 1983.